FOUNTAIN VALLEY, CALIFORNIA--(MARKET WIRE)--Jul 24, 2007 -- Sutura, Inc. (“Sutura”) (OTC BB:SUTU.OB - News), an innovative developer of minimally invasive vascular suturing devices, announced today that Dr. John Crew of the San Francisco Heart Institute and Seton Medical Center, has performed several tests of the SuperStitch EL in explanted porcine hearts. Dr. Crew sutured closed the Patent Foramen Ovale (PFO) in three hearts in the Sutura Lab facilities last week.